+254745601747

info@clinicalmedhub.com

Nairobi, Kenya

Olanzapine - Drug Details

Olanzapine (Zyprexa)

Classification
Atypical antipsychotic
Mechanism of Action
Indications
Schizophrenia, bipolar disorder
Dosage and Administration
5-20 mg orally once daily
Forms
Tablets, orally disintegrating tablets
Side Effects
Weight gain, drowsiness, increased appetite
Contraindications
Severe liver impairment, known hypersensitivity
Interactions
Caution with other CNS depressants
Precautions
Monitor for signs of metabolic syndrome
Pharmacokinetics
Half-life: 21-54 hours, metabolized in the liver
Pharmacodynamics
Modulates neurotransmitter pathways in the brain
Storage Requirements
Store at room temperature, protect from light
Patient Counselling
Counsel on the risk of weight gain and metabolic changes
Back to List
ClinicalMedHub - Modern Footer

ClinicalMedHub

Comprehensive medical resources, research tools, and professional networking for healthcare providers and patients worldwide.

Scroll down to see the modern footer design